Navigation Links
SPO Medical Retains American Capital Ventures for Investor Relations Services
Date:4/17/2008

NEW YORK, April 17 /PRNewswire-FirstCall/ -- SPO Medical Inc. (OTC: SPOM), a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices, today announced that it has retained the services of American Capital Ventures (ACV), a leading provider of comprehensive investor relations services to the small cap community, as an investor relations consultant.

Michael Braunold, President and Chief Executive Officer of SPO Medical commented, "As we continue to grow our revenues and enhance our distribution base, it has become increasingly important to reach out to the investment community. Our goal is to inform current and prospective investors of our financial prospects and the value proposition offered by our product pipeline and strategy." Mr. Braunold continued, "Our portable devices and new consumer applications will appeal to an ever growing number of markets globally. This is a powerful message we need to convey to investors and American Capital Ventures has a proven track record assisting small cap companies in communicating their message to the investor community."

Howard Gostfrand, President of American Capital Ventures, commented, "SPO Medical has positioned itself well in the burgeoning medical field of non-invasive devices. They have clearly laid the groundwork with key investments and strategic partnerships that have been delivering tangible results. Achieving revenues of $5 million in 2007 after only three years, and with an impressive product channel, SPOM is a perfect example of a promising undiscovered small cap company worth an investor's consideration."

About SPO Medical

SPO Medical (SPOM) is a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices to capture life-saving and life-enhancing information within four key markets: medical care; home and remote-care; sports and wellness; and safety and security. Its patented technology uses information gathered from the reflectance of light on the human blood stream, in a non-invasive manner, to monitor key vital signs. The Company distributes its products through a network of distributors and also licenses its technologies to appropriate client corporations for commercialization and distribution. For more information, visit http://www.spomedical.com.

About American Capital Ventures (ACV)

American Capital Ventures (ACV) is a boutique investor relations firm founded on the principals of hard work, professionalism and integrity. Our company offers emerging growth companies a different, more comprehensive approach to investor relations. ACV delivers highly effective investor communications counsel in conjunction with developing tangible brokerage relationships for our clients. Our unique blend of creating awareness while effectively increasing a company's trading volume has allowed us to continually expand our business. Our goal is to allow management the ability to focus on their core business, while assisting them in communicating their message and develop their investor relationships.

This press release contains forward-looking statements that involve substantial uncertainties and risks. These forward-looking statements are based upon our current expectations, estimates and projections about our business and our industry, and that reflect our beliefs and assumptions based upon information available to us at the date of this release. We caution readers that forward-looking statements are predictions based on our current expectations about future events. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that are difficult to predict. Our actual results, performance or achievements could differ materially from those expressed or implied by the forward-looking statements as a result of a number of factors, including but not limited to, changes in economic conditions generally and the medical devices market specifically, changes in technology, legislative or regulatory changes that affect us, the availability of working capital, the introduction of competing products, market acceptance of our new products, changes in our operating strategy or development plans and the risks and uncertainties discussed under the heading "Risk Factors" in Item 1 of our Annual Report on Form 10-KSB for the fiscal year ended December 31, 2007. We undertake no obligation to revise or update any forward-looking statement for any reason.

SPO Medical Contact:

Michael Braunold, President & CEO,

investors@spomedical.com ,

+1-805-823-8163;

ACV Contact:

Howard Gostfrand / David Sasso,

+1-305-918-7000,

info@amcapventures.com .

http://www.amcapventures.com


'/>"/>
SOURCE SPO Medical Inc
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Atom Medical Adopts Masimo Rainbow SET Technology
2. NYU Medical Center Changes Name to Honor Chairman of Board & Wife
3. BioMS Medical to present at EQUITIES Conference
4. Alta Bates Summit Medical Center Opens Two Warm, Supportive Patient Centers: Carol Ann Read Breast Health Center and Family Resource Center
5. James W. Backstrom, M.D., Named Chief Medical Officer of Foundation Radiology Group
6. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
7. Symmetry Medical Extends 10-K Filing Beyond April 14, 2008 Target
8. SPO Medical to Conduct Live Investor Meeting on April 29, 2008
9. ATS Medical Announces First North American Commercial Implant of the ATS 3f Aortic Bioprosthesis
10. Intradigm Licenses Key Next Generation RNA Interference (RNAi) Intellectual Property From University of Massachusetts Medical School
11. MEDRAD, Battelle Win Medical Design Excellence Award for MEDRAD XDS(TM) Extravasation Detector
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... International research firm Parks Associates announced today that Tom ... 2017 Annual Meeting , October 11 in Scottsdale, Arizona ... and how smart safety and security products impact the competitive landscape. ... Parks Associates: Smart Home Devices: Main Purchase Driver ... "The residential security market has experienced continued growth, and ...
(Date:10/9/2017)... , Oct. 9, 2017  BioTech Holdings ... mechanism by which its ProCell stem cell therapy ... limb ischemia.  The Company, demonstrated that treatment with ... of limbs saved as compared to standard bone ... molecule HGF resulted in reduction of therapeutic effect.  ...
(Date:10/9/2017)... ... October 09, 2017 , ... ... 5, 2017, in the medical journal, Epilepsia, Brain Sentinel’s SPEAC® System which ... video EEG, in detecting generalized tonic-clonic seizures (GTCS) using surface electromyography (sEMG). ...
(Date:10/6/2017)... ... October 06, 2017 , ... ... the healthcare and technology sector at their fourth annual Conference where founders, investors, ... inspiring speakers and the ELEVATE pitch competition showcasing early stage digital health and ...
Breaking Biology Technology:
(Date:5/6/2017)... 5, 2017 RAM Group , ... new breakthrough in biometric authentication based on a ... properties to perform biometric authentication. These new sensors are ... created by Ram Group and its partners. This sensor ... supply chains and security. Ram Group is a ...
(Date:4/18/2017)... SUNNYVALE, Calif. , April 18, 2017  Socionext Inc., a ... prototype of a media edge server, the M820, which features the ... face recognition software provided by Tera Probe, Inc., will be showcased ... and at the NAB show at the Las Vegas ... ...
(Date:4/13/2017)... , April 13, 2017 According to a new ... Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, ... IAM Market is expected to grow from USD 14.30 Billion in 2017 ... (CAGR) of 17.3%. ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):